. "Patrys continues to maintain an active program looking at
potential opportunities to license out the use of deoxymabs for certain, specified applications."
I wonder if PAB is having any discussions with Merck -
https://www.fiercepharma.com/pharma/jpm-merck-not-complacent-but-we-re-not-desperate-for-deals-ceo-says?mkt_tok=eyJpIjoiWldWa1ltRTJaVGd5WmpOaiIsInQiOiJqREdhVk1MUGFoNkNPYXpxc2dEeXQrWEc3Z25qRWtsZkJkNDBYcVNlcW9mTmFpcWIra0VmWmRiQ1oxMXpDR0YzRDQwTFR5a3VCbGFrTFBLTWNXdGlDXC9CdjhVRnk2SzNBRVJ0S2R5Sk9MdnFyTWZPaUF3cUUrWkZqYTViN09xMk5TTmFLT2xndGpxQm1TUWxTRXhkK3VRPT0ifQ%3D%3D&mrkid=61404167
Ann: Market update, page-28
Add PAB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $6.172M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.3¢ | 0.3¢ | $17.51K | 5.837M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 37 | 30968527 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 27089307 | 15 |
View Market Depth
| Last trade - 13.32pm 07/10/2024 (20 minute delay) ? |
| PAB (ASX) Chart |